Gene Query: TBC1D14

Dataset Description Geneva Score
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 35.98
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 35.77
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 34.81
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 31.16
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 29.51
Cell responses to dysregulated VZV-induced cell-cell fusion 27.16
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 25.51
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 25.39
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 25.39
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 25.13
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 24.82
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 20.89
RNA-seq of tumor cells following angiopellosis extravasation 20.21
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 20.19
Developmental stage specific chromosome architecture in human erythroid cells 19.89
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 19.89
Intron retention induced by microsatellite expansions as a disease biomarker. 18.97
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 18.93
Transcriptome wide analysis of classically and alternatively activated macrophages 18.67
SOX11 knockdown in B-ALL cell lines 18.62
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 18.54
Transcriptome analysis of Zika infected neural stem cells 18.51
Zika infected neural stem cells 18.51
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 18.36
ZIKV infection of monocytes activates inflammasome pathways 18.22
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 17.98
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 17.89
CD95/Fas ligand mRNA is toxic to cells 17.69
R430: A potent inbibitor of DNA and RNA viruses 17.42
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 17.4
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 17.4
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 17.18
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 16.99
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 16.77
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 16.76
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 16.36
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 15.68
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 15.68
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 15.66
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 15.56
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 15.35
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 14.73
Effect of disulfiram treatment on pediatric high grade glioma 14.54
Transcriptome of diurnal human blood neutrophils 14.49
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 14.49
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 14.49
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 14.4
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 14.34
Transcriptomic profiling of human peripheral blood-derived mast cells 14.34
Epigenomic landscape during organ formation in human early embryos 14.29
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 14.28
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 14.07
In situ CAPTURE of chromatin interactions by biotinylated dCas9 14.07
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 14.04
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 13.88
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 13.86
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 13.79
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 13.66
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 13.6
Effects of rFVIIIFc on human macrophages 13.31
The pioneer factor CEBPA modulates vitamin D signaling 13.29
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 13.29
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 13.28
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 13.19
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 13.11
Effect of Influenza virus infection on lncRNA expression in A549 cells 13.08
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 13.0
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 13.0
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 12.99
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 12.88
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 12.86
G-quadruplex structures mark human regulatory chromatin 12.82
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 12.82
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 12.76
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 12.62
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 12.61
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 12.53
Gene expression in PANC1 cells treated with Rakicidin 12.52
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 12.46
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 12.37
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 12.35
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 12.35
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 12.31
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 12.24
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 12.24
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 12.23
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 12.23
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 12.17
An RNA-centric dissection of host complexes controlling flavivirus infection 12.17
Oncogenic MYC induces a dependency on the spliceosome in human cancer 12.13
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 11.8
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 11.8
Glioblastoma stem cells infected by ZIKA virus 11.79
Generation and functional characterization of MDSC-like cells 11.77
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 11.65
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 11.59
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 11.56
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 11.55
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 11.54
Depicting early human development and germ cell origin with porcine embryos 11.44
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 11.4
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 11.38
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 11.29
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 11.17
Global response to chemotherapy-induced apoptosis 11.09
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 10.98
Tracking of dCas9-methyltransferase footprints 10.96
Lipid degradation promotes prostate cancer cell survival 10.9
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 10.89
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 10.89
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 10.89
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 10.65
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 10.57
Systematic discovery of endogenous human ribonucleoprotein complexes 10.51
The pause-initiation limit restricts transcription activation in human cells 10.5
Transcription control by the ENL YEATS domain in acute leukemia 10.45
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 10.45
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 10.29
MYC dependent mRNA translation shapes gene expression and cell biology 10.22
IMP3 regulated gene expression in breast cancer cells 10.21
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 10.17
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 10.15
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 10.06
Genome wide miR-191 target profile determined by RIP and gene expression profiling 10.06
Transcriptomes of human monocytes after ex vivo exposure to uric acid 9.85
RNA sequencing of matched nephrectomy samples [RNA-seq] 9.82
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 9.82
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 9.78
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 9.6
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 9.57
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 9.56
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 9.56
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 9.54
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 9.53
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 9.53
RNA-seq of YB5 cells treated with Proscillaridin A 9.52
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 9.52
DJ-1 is dispensable for human stem cell homeostasis 9.51
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 9.45
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 9.41
RNA-seq of human aneuploid cell lines with Trisomy 21 9.39
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 9.38
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 9.38
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 9.33
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 9.31
Ribosomal footprinting of CN34-Parental and CN34-LM1a 9.24
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 9.19
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 9.18
Dtx3L and Androgen Signaling in Prostate Cancer 9.18
mRNA expression profile of Lymphocytes by high-throuput sequencing 9.09
Ribosomal footprinting of MDA-Parental and MDA-LM2 9.08
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 8.95
Conservative alteration of chromosomal expression pattern across human solid tumor types 8.92
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 8.9
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 8.88
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 8.87
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 8.87
Expression data from miR340 overexpressing human A549 cells 8.82
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 8.78
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 8.77
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 8.65
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 8.65
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 8.62
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 8.58
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 8.47
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 8.47
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 8.42
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 8.42
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 8.37
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 8.33
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 8.31
Transcriptome analysis in Neobractatin treated cells 8.29
NAPRT activation of macrophages 8.27
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 8.2
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 8.11
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 8.09
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 8.08
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 7.97
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 7.96
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 7.96
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 7.93
Lineage specific differentiation is influenced by state of human pluripotency 7.93
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 7.91
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 7.88
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 7.86
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 7.86
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 7.86
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 7.8
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 7.76
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 7.76
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 7.7
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 7.69
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 7.69
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 7.69
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 7.67
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 7.66
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 7.66
Cajal bodies are linked to genome conformation [RNA-Seq] 7.65
Cajal bodies are linked to genome conformation 7.65
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 7.61
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 7.6
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 7.6
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 7.59
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 7.59
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 7.57
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 7.57
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 7.57
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 7.55
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 7.55
Inhibition of TNBC metastasis by Gpx1 7.53
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 7.49
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 7.48
Genome-wide analysis of the Integrator complex 7.45
Genome-wide analysis of the Integrator complex (HTS) 7.45
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 7.44
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 7.44
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 7.41
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 7.41
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 7.28
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 7.23
A Unique Epigenomic Landscape Defines Human Erythropoiesis 7.21
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 7.21
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 7.21
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 7.21
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 7.17
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 7.15
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 7.14
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 7.09
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 7.08
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 7.03
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 7.01
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 7.01
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 7.0
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 6.98
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 6.98
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 6.9
Tpl-2 small molecule project 6.75
Tpl-2 and MEK small molecule inhibitors 6.75
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 6.74
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 6.72
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 6.71
Genome-wide identification of cancer-specific alternative splicing in circRNA 6.7
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 6.68
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 6.66
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 6.62
RNA-seq melanoma 6.6
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 6.58
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 6.58
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 6.58
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 6.58
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 6.56
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 6.52
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 6.47
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 6.41
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 6.41
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 6.36
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 6.36
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 6.31
Seletive inhibition of CDK9 in DLBCL cell lines 6.3
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 6.21
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 6.18
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 6.14
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 6.14
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 6.14
Role of COP1 on MAP kinase transcriptional output in melanoma 6.14
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 6.12
RNA-seq analysis of differentiating human erythroblasts 6.11
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 6.04
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 6.03
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 6.03
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 6.01
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 6.0
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 5.99
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 5.96
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 5.91
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 5.88
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 5.86
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 5.85
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 5.8
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 5.65
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 5.64
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 5.63
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 5.61
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 5.5
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 5.5
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 5.44
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 5.42
Transcriptional responses of melanoma cells to BRAF inhibition 5.35
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 5.28
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 5.28
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 5.28
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 5.27
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 5.26
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 5.26
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 5.24
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 5.24
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 5.23
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 5.23
CD74 role in transcription regulation [RNA-seq] 5.22
CD74 role in transcription regulation 5.22
RNA transcriptome analysis during HSV-1 infection 5.21
Gene expression regulated by CSA and CSB in neuroblastoma cell line 5.17
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 5.17
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 5.15
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 5.13
KLF6-dependent transcription in renal cancer cells 5.13
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 5.11
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 5.09
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 5.08
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 5.07
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 5.06
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 5.05
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 5.05
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 5.04
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 5.01
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 5.0
miRNAs affected by antagomiR-17 treatment 4.97
LINE-2 transposable elements are a source of functional human microRNAs and target sites 4.97
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 4.83
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 4.82
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 4.82
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 4.8
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 4.8
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 4.76
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 4.67
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 4.67
Mapping interactions for the TNIP2 hub protein 4.67
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 4.63
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 4.62
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 4.62
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 4.62
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 4.54
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 4.51
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 4.44
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 4.44
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 4.44
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 4.38
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 4.38
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 4.38
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 4.36
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 4.32
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 4.31
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 4.3
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 4.28
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 4.25
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 4.23
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 4.21
Macrophage Ad5f35 M2 Challenge 4.17
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.16
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 4.16
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 4.15
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 4.11
m6A-dependent regulation of messenger RNA stability 4.11
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 3.98
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 3.98
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 3.83
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 3.83
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 3.8
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 3.77
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 3.75
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 3.74
MYCi975 regulates MYC target genes 3.73
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 3.48
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 3.48
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 3.47
Effect of drugs on transcriptomic profiles 3.41
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 3.35
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 3.33
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 3.31
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 3.3
Defective structural RNA processing in relapsing-remitting multiple sclerosis 3.28
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 3.26
The circadian transcriptional landscape in primary human mammary epithelial cells 3.12
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 3.04
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 3.04
Human ovarian granulosa cell transcriptome 3.03
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.96
Transcriptome sequencing of K-562 cells 2.93
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 2.93
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 2.91
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 2.81
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 2.81
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 2.77
RNA-seq of RKO cells with cTAZ KO or putback 2.75
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 2.68
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 2.63
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 2.55
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 2.53
Genome-wide discovery of human splicing branchpoints [RNAse] 2.5
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 2.5
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 2.49
Novel Targeting of Transcription and Metabolism in Glioblastoma 2.47
Transcriptome analysis of CNS leukemia 2.46
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 2.46
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 2.46
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 2.43
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 2.43
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.42
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 2.42
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 2.42
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 2.36
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 2.36
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 2.3
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 2.28
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 2.23
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 2.17
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 2.17
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 2.14
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 2.12
Gene expression of collecting duct carcinoma of the kidney 2.11
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 2.11
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 2.1
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 2.09
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 2.09
Aging-associated patterns in the expression of human endogenous retroviruses 2.07
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 2.03
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 2.03
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 2.01
Regulatory network controlling tumor-promoting inflammation in human cancers 2.01
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 1.99
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 1.99
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.96
Functional astrocytes differentiated from hiPSCs 1.9
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 1.84
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 1.8
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.78
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 1.69
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 1.69
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 1.66
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 1.65
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 1.65
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 1.65
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 1.65
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.64
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 1.6
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.59
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 1.57
Total RNA-Seq data from leukemic patients with complex structural variants 1.54
Differential responses of human fetal brain neural stem cells to Zika virus infection 1.48
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 1.41
Trascriptome of thyroid cancer-induced macrophages 1.41
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.39
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.35
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 1.33
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 1.32
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 1.28
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.25
Patient-derived xenograft platform for metastatic melanoma 1.16
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.13
Transcriptome analysis of peripheral blood monocytes 1.11
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 1.07
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.07
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 1.0
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.99
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.96
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.96
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.82
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.77
Identification of a LIF-responsive replication-competent human β cell 0.74
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.73
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.72
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.72
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.71
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 0.69
Impact on erythroid progenitor type on erythroid differntiation 0.67
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 0.67
Global transcriptome analysis of WT versus HEB-/- hESCs 0.63
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.61
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.59
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.5
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.5
RNA-seq of CD33 KO and control HSPCs 0.45
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.43
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.43
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 0.37
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.36
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.36
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.3
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.28
Expression analysis of the TAF1 syndrome 0.27
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.23
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 0.22
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.2
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.19
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.19
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.18
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.14
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.12
naive T cell heterogeneity after neonatal thymectomy 0.1
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.1
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.09
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.09
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 0.09
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 0.09
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.06
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.05
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.03
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.02
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.01
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation